At-home Breast Oncology Care Delivered With E-health Solutions
Launched by UNIVERSITY HEALTH NETWORK, TORONTO · Aug 9, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
The ABODE study is exploring a new way to support women diagnosed with breast cancer through an easy-to-use app. This app is designed to help patients and their healthcare providers connect virtually, making it easier to get information, have appointments, and track how patients are feeling throughout their treatment. The main goal of the study is to see if using this app helps women become more engaged and active in their care compared to those receiving standard treatment without the app.
To participate in this study, women must be at least 18 years old, have been diagnosed with their first invasive breast cancer, and be planning to have surgery as their first treatment step. They also need to have internet access and be comfortable using an electronic device. Participants will use the app for one year and share their experiences, helping researchers understand how effective this technology can be in improving care for breast cancer patients.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Females (assigned female at birth)\*
- • Diagnosed with first, primary invasive BC
- • Must have surgery as their first step in treatment pathway
- • Age≥18
- • Access to an electronic device with connection to the internet
- • A valid email address
- • Can communicate in English \*Since BC risk is sex-related and based on physiological values, our inclusion criteria are based on sex (not gender)
- Exclusion criteria:
- • Males (assigned male at birth), as BC surgical treatment options and experiences are different
- • Diagnosed with non-operable breast cancer
- • Stage 4/metastatic (whether determined at diagnosis or during surgery)
- • Those with hearing or visual challenges
- • Neo-adjuvant chemotherapy
- • Should not be enrolled in any other UHN study using an e-Health application
- • Breast cancer surgery is scheduled for less 5 business days after enrollment
About University Health Network, Toronto
University Health Network (UHN), based in Toronto, is a leading academic health sciences center dedicated to advancing patient care through innovative research and education. As a prominent sponsor of clinical trials, UHN integrates cutting-edge scientific discoveries with clinical practice, facilitating the development of new therapies and treatment modalities. With a commitment to improving health outcomes, UHN collaborates with a diverse network of researchers, healthcare professionals, and industry partners, fostering an environment that prioritizes patient safety and ethical standards in clinical research. Through its extensive resources and expertise, UHN plays a pivotal role in transforming healthcare and enhancing the quality of life for patients both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Patients applied
Trial Officials
Tulin Cil, MD, MEd
Principal Investigator
University Health Network, Toronto
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported